IPO Trending
AGARWALEYEEQ / NSE, BSEListed
Dr. Agarwals Health Care

Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.

₹382 - ₹4021.55x sub
Listed Price₹402.00
Listing Gain+0.00%

Subscription Status

1.55xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB4.64x
Popular / Warm DemandOffered: 1,45,19,200 sh
Nib0.40x
Steady / DevelopingOffered: 1,08,89,400 sh
Hnis(10l +)0.31x
Steady / DevelopingOffered: 72,59,600 sh
Hnis (2-10l)0.56x
Steady / DevelopingOffered: 36,29,800 sh
Retail0.41x
Steady / DevelopingOffered: 2,54,08,599 sh
Employees0.27x
Steady / DevelopingOffered: 15,79,399 sh
Shareholder0.52x
Steady / DevelopingOffered: 11,29,574 sh
CategoryOfferedAppliedTimes
QIB1,45,19,2006,73,61,2804.64x
Nib1,08,89,40043,07,3100.4x
Hnis(10l +)72,59,60022,85,9550.31x
Hnis (2-10l)36,29,80020,21,3550.56x
Retail2,54,08,5991,05,40,2850.41x
Employees15,79,3994,25,5650.27x
Shareholder11,29,5745,83,9400.52x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB2,707.92583.674.64x
Retail423.721,021.430.41x
Hnis 2+81.26145.920.56x
Hnis 10+91.9291.840.31x
Employees17.1163.490.27x
Shareholder23.4745.410.52x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
Retail7,25,9602,16,5840.30x
Hnis(10l +)13,8288460.06x
Hnis (2-10l)6,9143,4320.50x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Dr. Agarwals Health Care IPO Subscription Demand

Live subscription status and bidding analysis for Dr. Agarwals Health Care (AGARWALEYE) IPO. The issue is subscribed 1.55x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions